These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33250761)

  • 1. Metabolic Profiling of Cognitive Aging in Midlife.
    Huo Z; Rana BK; Elman JA; Dong R; Engelman CD; Johnson SC; Lyons MJ; Franz CE; Kremen WS; Zhao J
    Front Aging Neurosci; 2020; 12():555850. PubMed ID: 33250761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of the Vietnam Era Twin Study of Aging (VETSA).
    Kremen WS; Franz CE; Lyons MJ
    Twin Res Hum Genet; 2019 Dec; 22(6):783-787. PubMed ID: 31933447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
    Darst BF; Huo Z; Jonaitis EM; Koscik RL; Clark LR; Lu Q; Kremen WS; Franz CE; Rana B; Lyons MJ; Hogan KJ; Zhao J; Johnson SC; Engelman CD
    J Alzheimers Dis; 2021; 79(3):1041-1054. PubMed ID: 33427733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.
    Chua XY; Chai YL; Chew WS; Chong JR; Ang HL; Xiang P; Camara K; Howell AR; Torta F; Wenk MR; Hilal S; Venketasubramanian N; Chen CP; Herr DR; Lai MKP
    Alzheimers Res Ther; 2020 Sep; 12(1):122. PubMed ID: 32998767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementia.
    Chua XY; Torta F; Chong JR; Venketasubramanian N; Hilal S; Wenk MR; Chen CP; Arumugam TV; Herr DR; Lai MKP
    Alzheimers Res Ther; 2023 Dec; 15(1):214. PubMed ID: 38087395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early identification and heritability of mild cognitive impairment.
    Kremen WS; Jak AJ; Panizzon MS; Spoon KM; Franz CE; Thompson WK; Jacobson KC; Vasilopoulos T; Vuoksimaa E; Xian H; Toomey R; Lyons MJ
    Int J Epidemiol; 2014 Apr; 43(2):600-10. PubMed ID: 24370560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes, environment, and time: the Vietnam Era Twin Study of Aging (VETSA).
    Kremen WS; Thompson-Brenner H; Leung YM; Grant MD; Franz CE; Eisen SA; Jacobson KC; Boake C; Lyons MJ
    Twin Res Hum Genet; 2006 Dec; 9(6):1009-22. PubMed ID: 17254445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midlife activity predicts risk of dementia in older male twin pairs.
    Carlson MC; Helms MJ; Steffens DC; Burke JR; Potter GG; Plassman BL
    Alzheimers Dement; 2008 Sep; 4(5):324-31. PubMed ID: 18790459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-year prediction of mild cognitive impairment aided by Alzheimer's brain signatures at mean age 56.
    Williams ME; Elman JA; McEvoy LK; Andreassen OA; Dale AM; Eglit GML; Eyler LT; Fennema-Notestine C; Franz CE; Gillespie NA; Hagler DJ; Hatton SN; Hauger RL; Jak AJ; Logue MW; Lyons MJ; McKenzie RE; Neale MC; Panizzon MS; Puckett OK; Reynolds CA; Sanderson-Cimino M; Toomey R; Tu XM; Whitsel N; Xian H; Kremen WS
    Brain Commun; 2021; 3(3):fcab167. PubMed ID: 34396116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VETSA: the Vietnam Era Twin Study of Aging.
    Kremen WS; Franz CE; Lyons MJ
    Twin Res Hum Genet; 2013 Feb; 16(1):399-402. PubMed ID: 23110957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.
    Logue MW; Panizzon MS; Elman JA; Gillespie NA; Hatton SN; Gustavson DE; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Neale MC; Reynolds CA; Tu X; Kremen WS
    Mol Psychiatry; 2019 Mar; 24(3):421-430. PubMed ID: 29487403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 35-year longitudinal assessment of cognition and midlife depression symptoms: the Vietnam Era Twin Study of Aging.
    Franz CE; Lyons MJ; O'Brien R; Panizzon MS; Kim K; Bhat R; Grant MD; Toomey R; Eisen S; Xian H; Kremen WS
    Am J Geriatr Psychiatry; 2011 Jun; 19(6):559-70. PubMed ID: 21606899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of
    den Hoedt S; Dorst-Lagerwerf KY; de Vries HE; Rozemuller AJM; Scheltens P; Walter J; Sijbrands EJG; Martinez-Martinez P; Verhoeven AJM; Teunissen CE; Mulder MT
    J Alzheimers Dis Rep; 2023; 7(1):339-354. PubMed ID: 37220621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention.
    Koscik RL; Berman SE; Clark LR; Mueller KD; Okonkwo OC; Gleason CE; Hermann BP; Sager MA; Johnson SC
    J Int Neuropsychol Soc; 2016 Nov; 22(10):1016-1025. PubMed ID: 27903330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease.
    Huang YL; Lin CH; Tsai TH; Huang CH; Li JL; Chen LK; Li CH; Tsai TF; Wang PN
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
    Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
    Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention.
    Mueller KD; Norton D; Koscik RL; Morris MC; Jonaitis EM; Clark LR; Fields T; Allison S; Berman S; Kraning S; Zuelsdorff M; Okonkwo O; Chin N; Carlsson CM; Bendlin BB; Hermann BP; Johnson SC
    PLoS One; 2020; 15(4):e0221985. PubMed ID: 32324741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.